Home/Accipiter Biosciences/Matthew Bick, Ph.D.

MB

Matthew Bick, Ph.D.

Chief Executive Officer

Accipiter Biosciences

Therapeutic Areas

Autoimmunity Oncology

Accipiter Biosciences Pipeline

Drug	Indication	Phase
Autoimmunity Program	Autoimmune Disease	Preclinical
Oncology Program	Cancer	Preclinical

Leadership Team at Accipiter Biosciences

Javier Castellanos, Ph.D.

Chief Technology Officer & Co-founder

View full Accipiter Biosciences profile